Moderna and Merck's Phase 3 melanoma vaccine trial showed positive results, but full data and FDA approval are still pending ...

But it can easily be thrown off by the background color of a person’s skin. In other words, the AI model doesn’t learn to ...

Russ Read-Barrow hopes that by sharing what has been helping him, he can help other people with cancer.

Researchers trained AI on how expert pathologists look for signs of cancer in patient samples, improving the algorithm's ...

Getting there, however, will require enormous amounts of computing power, Haas said.

Model trained on millions of protein measurements can gauge drug effectiveness in tissue samples taken from people with ...

Cornell researchers have used artificial intelligence to uncover a previously unknown way cells control how proteins move ...

The head of chip designer Arm says modelling how a DNA marker is impacted by cancer cannot be done now, but computers are ...

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced ...

New funding is coming for projects throughout the state, including two important medical projects at Binghamton University.

Moderna built an artificial intelligence that reads a patient’s tumor and decides what that patient’s medicine should be.

Ataraxis AI, a company building clinical AI tools to personalize cancer care, today announced scientific breakthroughs and validation results of Ataraxis’s AI models.